Related Experiment Videos
Atypical multisystem inflammatory syndrome in children presenting with 1-month persistent fever in a 17-month-old: A
Mohammad Noor Katranjy1, Ahmad Alabdlilrazzak1, Mohamad Alharbi1
1Faculty of Medicine, Hama University, Syria.
Insights
Multisystem Inflammatory Syndrome in Children (MIS-C) is a severe complication of COVID-19 in youth. This case report details a toddler
Area of Science:
- Pediatrics
- Infectious Diseases
- Immunology
Background:
- Multisystem Inflammatory Syndrome in Children (MIS-C) is a rare but serious complication of coronavirus disease 2019 (COVID-19).
- MIS-C affects individuals under 19, presenting with diverse and potentially severe clinical manifestations.
- Management of MIS-C is complex due to varied presentations and treatment responses.
Purpose of the Study:
- To describe a case of MIS-C in a toddler with prolonged fever and gastrointestinal symptoms.
- To highlight the diagnostic challenges and successful treatment of MIS-C.
- To contribute to the understanding of MIS-C presentation in young children without prior documented SARS-CoV-2 infection.
Main Methods:
- Case report of a toddler with a 30-day relapsing fever, gastrointestinal symptoms, and rash.
- Clinical and laboratory investigations were performed.
- Treatment involved intravenous immunoglobulin and corticosteroids.
Main Results:
- The patient, a toddler with no prior documented severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, presented with prolonged fever, gastrointestinal issues, and rash.
- Diagnosis of MIS-C was confirmed after extensive evaluation.
- The child showed a positive response to treatment with intravenous immunoglobulin and corticosteroids.
Conclusions:
- MIS-C can occur in young children even without a history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
- Early diagnosis and prompt treatment with immunomodulatory therapies are crucial for favorable outcomes in MIS-C.
- This case underscores the importance of considering MIS-C in pediatric patients with unexplained prolonged fever and systemic inflammation.
Abstract:
Multisystem Inflammatory Syndrome in Children is a serious complication associated with coronavirus disease 2019 that commonly affects individuals under 19 years of age. This condition can present with a wide spectrum of clinical manifestations, some of which may be severe or life-threatening. Management can be challenging due to the variability in clinical presentation and response to therapy. This report describes the case of a toddler with no previously documented severe acute respiratory syndrome coronavirus 2 infection who presented with a 30-day relapsing fever that demonstrated partial response to antipyretics and was associated with gastrointestinal symptoms and a skin rash. Following extensive clinical and laboratory investigations, the patient was diagnosed with multisystem inflammatory syndrome in children and was successfully treated with intravenous immunoglobulin and corticosteroids.
Related Concept Videos
Patterns of Fever
Rocky Mountain Spotted Fever
Myocarditis II: Clinical Features and Diagnostic Tests
Atypical Pneumonia
Types of Fever
Here are the different types of fever:
Increased Body Temperature